Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 1845 participants.
Also called NCT01858077
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,845 participants
- Registry
-
NCT01858077
-
- Other papers using this trial's data
- Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Unknown status
Technical summary
Registry record NCT01858077. Randomized; single masking; primary purpose treatment. Start 2013-08 (registry gives no type); primary completion 2017-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial
- Acronym
- AIDA
- Condition
- Coronary Artery Disease
- Condition
- Myocardial Infarction
- Intervention (Device)
- ABSORB BVS™
- Intervention (Device)
- XIENCE™
- Lead sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Record details
- Record id
cardio:ct-nct01858077- Content hash
b91bc02f04af0adccc169193a57197ad18539e59ed9332dfa2587e3f1ef0da18